Related references
Note: Only part of the references are listed.ICTV Virus Taxonomy Profile: Pneumoviridae
Bert Rima et al.
JOURNAL OF GENERAL VIROLOGY (2017)
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
Nadine G. Rouphael et al.
LANCET (2017)
Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin
Mark R. Prausnitz
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 8 (2017)
Towards an evidence based approach for the development of adjuvanted vaccines
Derek T. O'Hagan et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Microneedles for vaccine delivery: challenges and future perspectives
Chong In Shin et al.
THERAPEUTIC DELIVERY (2017)
Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods
Anto Vrdoljak et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
April M. Killikelly et al.
SCIENTIFIC REPORTS (2016)
The success of microneedle-mediated vaccine delivery into skin
Sarah Marshall et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection
Young-Tae Lee et al.
VIROLOGY (2015)
Bee venom phospholipase A2 suppresses allergic airway inflammation in an ovalbumin-induced asthma model through the induction of regulatory T cells
Soojin Park et al.
IMMUNITY INFLAMMATION AND DISEASE (2015)
Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis
Hye Suk Hwang et al.
ANTIVIRAL RESEARCH (2014)
Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity
Bao-Zhong Wang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology
Jorge C. G. Blanco et al.
VACCINE (2014)
Long-Term Protective Immunity from an Influenza Virus-Like Particle Vaccine Administered with a Microneedle Patch
Fu-Shi Quan et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Microneedle-mediated vaccine delivery: Harnessing cutaneous immunobiology to improve efficacy
Sharifa Al-Zahrani et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
Li Liu et al.
LANCET (2012)
Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant
Sol Kim et al.
PLOS ONE (2012)
Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
Tobias Kamphuis et al.
PLOS ONE (2012)
Multiple CD4+ T Cell Subsets Produce Immunomodulatory IL-10 During Respiratory Syncytial Virus Infection
Kayla A. Weiss et al.
JOURNAL OF IMMUNOLOGY (2011)
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Fu-Shi Quan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage
Yeu-Chun Kim et al.
PHARMACEUTICAL RESEARCH (2011)
Formulation of Microneedles Coated with Influenza Virus-like Particle Vaccine
Yeu-Chun Kim et al.
AAPS PHARMSCITECH (2010)
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity
Yeu-Chun Kim et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles
Fu-Shi Quan et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization
Fu-Shi Quan et al.
JOURNAL OF VIROLOGY (2010)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin
Fu-Shi Quan et al.
PLOS ONE (2009)
Comparison of Histochemical Methods for Murine Eosinophil Detection in an RSV Vaccine-enhanced Inflammation Model
David K. Meyerholz et al.
TOXICOLOGIC PATHOLOGY (2009)
IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease
Elaine M. Castilow et al.
JOURNAL OF IMMUNOLOGY (2008)
CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease
Matthew R. Olson et al.
JOURNAL OF IMMUNOLOGY (2007)
Coating formulations for microneedles
Harvinder S. Gill et al.
PHARMACEUTICAL RESEARCH (2007)
The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease
Marina S. Boukhvalova et al.
VACCINE (2006)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Vβ14+ T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV
TR Johnson et al.
JOURNAL OF VIROLOGY (2004)
Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma
FD Martinez
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine
GA Prince et al.
JOURNAL OF GENERAL VIROLOGY (2001)
The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2CD4+ T cell responses
SM Varga et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
